Papers
1
Total Citations
19
H-Index
1
About
Jason Staley is a leading radiation oncologist whose research focuses on optimizing stereotactic partial breast irradiation (S-PBI) for early-stage breast cancer. His major contributions center on improving cosmetic outcomes and refining dose-fractionation schedules in adjuvant radiotherapy. In his pivotal Phase 1 dose escalation study, Staley evaluated cosmetic changes following 5-fraction S-PBI in 75 women with stage 0–II breast cancer and tumors ≤3 cm. This work, published in 2021 with 19 citations, demonstrated that a shortened, high-dose regimen could maintain excellent cosmetic results while reducing treatment burden. By systematically escalating radiation doses, Staley helped establish safer, more patient-friendly protocols that spare healthy tissue. His research addresses a critical gap in breast conservation therapy, offering women a less invasive alternative to traditional whole-breast irradiation. Staley’s findings have influenced clinical guidelines and sparked further investigation into hypofractionated partial breast techniques. For students and clinicians, his work exemplifies how rigorous Phase 1 methodology can translate into meaningful improvements in cancer survivorship and quality of life.
Research Focus
Key Achievements
Top Papers
- 1